Summary & Overview
HCPCS J8540: Dexamethasone, Oral, 0.25 mg
HCPCS Level II code J8540 designates oral dexamethasone 0.25 mg. This medication code is used nationally to capture dispensing or administration of a low-dose oral corticosteroid commonly used for anti-inflammatory, immunosuppressive, or antiemetic indications. Accurate coding of J8540 supports appropriate billing, benefit adjudication, and medication utilization tracking across outpatient settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national overview of clinical context for dexamethasone use, payer coverage considerations, common billing modifiers and administration contexts, and benchmarking topics relevant to outpatient medication billing. The publication outlines how J8540 is reported on claims, typical sites of service where the code appears, and practical coding notes to inform revenue cycle teams and clinicians.
What readers will learn: how J8540 maps to outpatient medication services, typical reimbursement and claim considerations across major payers, common modifiers seen with medication dispensing claims, and areas where policy updates or payer-specific rules may affect billing. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code J8540 represents dexamethasone, oral, 0.25 mg. This code is used to bill for oral dexamethasone in the listed strength when dispensed or administered in outpatient settings. The service type is medication dispensing or pharmacist-administered oral corticosteroid therapy. The typical site of service is ambulatory outpatient settings such as physician offices, clinics, outpatient infusion centers, and retail or clinic-based pharmacies.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult receiving an outpatient oral corticosteroid for management of inflammatory or allergic conditions. For example, a 45-year-old female presents to an urgent care clinic with acute exacerbation of asthma and significant airway inflammation after failing home inhaler therapy. The clinician prescribes oral J8540 (dexamethasone, oral, 0.25 mg unit dose formulation) to provide short-course systemic corticosteroid therapy. The workflow: clinician documents history, exam, and assessment supporting systemic steroid; determines dose and quantity; documents indication and duration in the medical record; dispenses or writes a prescription for the appropriate number of unit-dose tablets or milligrams; applies appropriate diagnosis code(s) on the claim; and appends relevant modifier(s) if billing circumstances require (e.g., professional vs. facility billing, medically necessary documentation exceptions, or split/shared services). Typical sites of service include outpatient clinic, urgent care center, emergency department, and pharmacy dispensing for take-home therapy. Common clinical indications include asthma exacerbation, acute allergic reaction, chronic obstructive pulmonary disease flare, severe contact dermatitis, and certain autoimmune flares where short-course oral dexamethasone is appropriate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management (E/M) service by the same physician on the day of a procedure |